Health Related QOL, Depression and Lifestyle Changes in Insulin Resistant Adolescents
NCT ID: NCT00493259
Last Updated: 2021-01-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
78 participants
OBSERVATIONAL
2007-06-30
2008-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Weight Loss Study-Mechanism Underlying the Improvement of Insulin Resistance in Response to Weight Loss
NCT01780870
Sestrin-2 Levels and Insulin Resistance
NCT06779721
Effect of Medical Interventions in Insulin Resistance on Prevalence of Abnormal Glucose Tolerance
NCT02502344
How Quickly Can the Effects of Excessive Caloric Intake on Insulin Resistance be Reversed?
NCT02505958
Resveratrol for the Treatment of Non Alcoholic Fatty Liver Disease and Insulin Resistance in Overweight Adolescents
NCT02216552
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Health-Related Quality of Life instrument
Adolescents will fill out questionnaires regarding quality of life and dealing with diagnosis of Insulin Resistance Syndrome
Depression Scale for Children (CES-DC)
questionnaire
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Historical control: Patients 11-19 years of age seen in the Insulin Resistance Clinic during the prior four months
Exclusion Criteria
* Diagnosis of Type 2 Diabetes
* Taking Metformin before the initial visit
* Taking medication for or diagnosis of a psychiatric condition prior to initial visit
* Developmentally delayed
11 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's Mercy Hospital Kansas City
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Adrienne Platt, MS, CPNP
Role: PRINCIPAL_INVESTIGATOR
Children's Mercy Hospital Kansas City
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's Mercy Hospital
Kansas City, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
07 02-037E
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.